Sandra was Senior Vice President at OncoSec, and Oncology Clinical Trial Consultant at Fate Therapeutics. Sandra Aung joined Johnson & Johnson in 2023.
Sandra Aung is currently Chief Clinical Officer at Ambrx - View - Ambrx org chart
Create your alert
to follow the career of Sandra Aung.
Sandra Aung has a PhD in Microbiology and Immunology from Vanderbilt University in 2000 and a Post-Doctoral in Automimmunity from The Scripps Research Institute in 2002.
They have also studied at Vanderbilt University :
Find more alumni from Vanderbilt University
They have also studied at The Scripps Research Institute :
Find more alumni from The Scripps Research Institute
Do you need to know more about Sandra Aung? More results.
Report an error
Update the org chart details of Sandra Aung.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.